首页 > 最新文献

Clinical eHealth最新文献

英文 中文
Clinical prognosis and risk factors of death for COVID-19 patients complicated with coronary heart disease/diabetes/hypertension-a retrospective, real-world study COVID-19合并冠心病/糖尿病/高血压患者的临床预后和死亡危险因素——一项回顾性现实研究
Pub Date : 2024-12-18 DOI: 10.1016/j.ceh.2024.12.002
Da-Wei Yang , Hui-Fen Weng , Jing Li , Min-Jie Ju , Hao Wang , Yi-Chen Jia , Xiao-Dan Wang , Jia Fan , Zuo-qin Yan , Jian Zhou , Cui-Cui Chen , Yin-Zhou Feng , Xiao-Yan Chen , Dong-Ni Hou , Xing-Wei Lu , Wei Yang , Yin Wu , Zheng-Guo Chen , Tao Bai , Xiao-Han Hu , Yuan-Lin Song

Objectives

To explore the clinical prognosis and the risk factors of death from COVID-19 patients complicated with one of the three major comorbidities (coronary heart disease, diabetes, or hypertension) based on real-world data.

Methods

This single-centre retrospective real-world study investigated all in-hospital patients who were transferred to the Coronavirus Special Ward of the Elderly Center of Zhongshan Hospital from March to June 2022 with a positive COVID-19 virus nucleic acid test and with at least one of the three comorbidities (coronary heart disease, diabetes or hypertension). Clinical data and laboratory test results of eligible patients were collected. A multivariate logistic regression analysis was performed to explore the risk associated with the prognosis.

Results

For the 1,281 PCR-positive patients at the admission included in the analysis, the mean age was 70.5 ± 13.7 years, and 658 (51.4 %) were males. There were 1,092 (85.2 %) patients with hypertension, 477(37.2 %) patients with diabetes, and 124 (9.7 %) patients with coronary heart disease. The length of hospital stay (LOS) was 9.2 ± 5.1 days. Among all admitted patients,1112 (91.5 %) were fully recovered, 77 (6.9 %) were improved, and 29 (2.6 %) died. Over the hospitalization, 172 (13.4 %) PCR-positive patients experienced rebound COVID following initial recovery with a negative PCR test. A multivariate logistic regression analysis showed that vaccination had no protective effects in this study population; Paxlovid was associated with a lower risk of death(OR = 0.98, 95 % CI: 0.95–1.00). Whereas the presence of solid malignancies and nerve system disease were significantly associated with increased risk of death (OR = 1.04, 95 % CI:1.02–1.05; OR = 1.10, 95 % CI:1.05–1.14; OR = 1.08, 95 % CI:1.03–1.13; respectively).

Conclusion

The vast majority of the hospitalized COVID patients were fully recovered. Paxlovid was associated with a lower risk of death. In contrast, the presence of solid malignancies and nerve system disease and some treatments were all significantly associated with an increased risk of death.
目的根据实际数据,探讨新冠肺炎合并冠心病、糖尿病或高血压三种主要合并症之一的临床预后及死亡危险因素。方法本研究采用单中心回顾性现实世界研究方法,对2022年3月至6月转入中山医院老年中心冠状病毒专科病房的所有COVID-19病毒核酸检测阳性且伴有冠心病、糖尿病或高血压三种合并症中至少一种的住院患者进行调查。收集符合条件的患者的临床资料和实验室检查结果。采用多因素logistic回归分析探讨风险与预后的关系。结果纳入分析的1281例pcr阳性患者,平均年龄70.5±13.7岁,男性658例(51.4%)。高血压1092例(85.2%),糖尿病477例(37.2%),冠心病124例(9.7%)。住院时间(LOS)为9.2±5.1 d。在所有住院患者中,完全康复1112例(91.5%),好转77例(6.9%),死亡29例(2.6%)。在住院期间,172例(13.4%)PCR阳性患者在PCR检测阴性的初步康复后出现反弹。多因素logistic回归分析显示,疫苗接种在该研究人群中没有保护作用;Paxlovid与较低的死亡风险相关(OR = 0.98, 95% CI: 0.95-1.00)。而实体恶性肿瘤和神经系统疾病的存在与死亡风险增加显著相关(OR = 1.04, 95% CI: 1.02-1.05;Or = 1.10, 95% ci: 1.05-1.14;Or = 1.08, 95% ci: 1.03-1.13;分别)。结论绝大多数住院新冠肺炎患者完全康复。Paxlovid与较低的死亡风险相关。相反,实体恶性肿瘤和神经系统疾病的存在以及一些治疗都与死亡风险增加显著相关。
{"title":"Clinical prognosis and risk factors of death for COVID-19 patients complicated with coronary heart disease/diabetes/hypertension-a retrospective, real-world study","authors":"Da-Wei Yang ,&nbsp;Hui-Fen Weng ,&nbsp;Jing Li ,&nbsp;Min-Jie Ju ,&nbsp;Hao Wang ,&nbsp;Yi-Chen Jia ,&nbsp;Xiao-Dan Wang ,&nbsp;Jia Fan ,&nbsp;Zuo-qin Yan ,&nbsp;Jian Zhou ,&nbsp;Cui-Cui Chen ,&nbsp;Yin-Zhou Feng ,&nbsp;Xiao-Yan Chen ,&nbsp;Dong-Ni Hou ,&nbsp;Xing-Wei Lu ,&nbsp;Wei Yang ,&nbsp;Yin Wu ,&nbsp;Zheng-Guo Chen ,&nbsp;Tao Bai ,&nbsp;Xiao-Han Hu ,&nbsp;Yuan-Lin Song","doi":"10.1016/j.ceh.2024.12.002","DOIUrl":"10.1016/j.ceh.2024.12.002","url":null,"abstract":"<div><h3>Objectives</h3><div>To explore the clinical prognosis and the risk factors of death from COVID-19 patients complicated with one of the three major comorbidities (coronary heart disease, diabetes, or hypertension) based on real-world data.</div></div><div><h3>Methods</h3><div>This single-centre retrospective real-world study investigated all in-hospital patients who were transferred to the Coronavirus Special Ward of the Elderly Center of Zhongshan Hospital from March to June 2022 with a positive COVID-19 virus nucleic acid test and with at least one of the three comorbidities (coronary heart disease, diabetes or hypertension). Clinical data and laboratory test results of eligible patients were collected. A multivariate logistic regression analysis was performed to explore the risk associated with the prognosis.</div></div><div><h3>Results</h3><div>For the 1,281 PCR-positive patients at the admission included in the analysis, the mean age was 70.5 ± 13.7 years, and 658 (51.4 %) were males. There were 1,092 (85.2 %) patients with hypertension, 477(37.2 %) patients with diabetes, and 124 (9.7 %) patients with coronary heart disease. The length of hospital stay (LOS) was 9.2 ± 5.1 days. Among all admitted patients,1112 (91.5 %) were fully recovered, 77 (6.9 %) were improved, and 29 (2.6 %) died. Over the hospitalization, 172 (13.4 %) PCR-positive patients experienced rebound COVID following initial recovery with a negative PCR test. A multivariate logistic regression analysis showed that vaccination had no protective effects in this study population; Paxlovid was associated with a lower risk of death(OR = 0.98, 95 % CI: 0.95–1.00). Whereas the presence of solid malignancies and nerve system disease were significantly associated with increased risk of death (OR = 1.04, 95 % CI:1.02–1.05; OR = 1.10, 95 % CI:1.05–1.14; OR = 1.08, 95 % CI:1.03–1.13; respectively).</div></div><div><h3>Conclusion</h3><div>The vast majority of the hospitalized COVID patients were fully recovered. Paxlovid was associated with a lower risk of death. In contrast, the presence of solid malignancies and nerve system disease and some treatments were all significantly associated with an increased risk of death.</div></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"8 ","pages":"Pages 26-31"},"PeriodicalIF":0.0,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143563476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conversational AI with large language models to increase the uptake of clinical guidance 具有大型语言模型的会话AI,以增加临床指导的吸收
Pub Date : 2024-12-01 DOI: 10.1016/j.ceh.2024.12.001
Gloria Macia , Alison Liddell , Vincent Doyle
The rise of large language models (LLMs) and conversational applications, like ChatGPT, prompts Health Technology Assessment (HTA) bodies, such as NICE, to rethink how healthcare professionals access clinical guidance. Integrating LLMs into systems like Retrieval-Augmented Generation (RAG) offers potential solutions to current LLMs’ problems, like the generation of false or misleading information. The objective of this paper is to design and debate the value of an AI-driven system, similar to ChatGPT, to enhance the uptake of clinical guidance within the National Health Service (NHS) of the UK. Conversational interfaces, powered by LLMs, offer healthcare practitioners clear benefits over traditional ways of getting clinical guidance, such as easy navigation through long documents, blending information from various trusted sources, or expediting evidence-based decisions in situ. But, putting these interfaces into practice brings new challenges for HTA bodies, like assuring quality, addressing data privacy concerns, navigating existing resource constraints, or preparing the organization for innovative practices. Rigorous empirical evaluations are necessary to validate their effectiveness in increasing the uptake of clinical guidance among healthcare practitioners. A feasible evaluation strategy is elucidated in this research while its implementation remains as future work.
大型语言模型(llm)和会话应用程序(如ChatGPT)的兴起,促使健康技术评估(HTA)机构(如NICE)重新思考医疗保健专业人员如何获得临床指导。将法学硕士集成到诸如检索增强生成(RAG)之类的系统中,为当前法学硕士的问题提供了潜在的解决方案,例如生成虚假或误导性信息。本文的目的是设计和讨论类似于ChatGPT的人工智能驱动系统的价值,以增强英国国家卫生服务体系(NHS)对临床指导的吸收。由llm提供支持的会话界面为医疗保健从业者提供了明显优于传统方式的临床指导,例如轻松浏览冗长的文档,混合来自各种可信来源的信息,或在现场加快基于证据的决策。但是,将这些接口付诸实践给HTA机构带来了新的挑战,如确保质量,解决数据隐私问题,导航现有资源限制,或为组织创新实践做好准备。严格的经验评估是必要的,以验证其有效性,在增加医疗保健从业人员的临床指导吸收。本研究提出了一种可行的评价策略,具体实施仍需进一步研究。
{"title":"Conversational AI with large language models to increase the uptake of clinical guidance","authors":"Gloria Macia ,&nbsp;Alison Liddell ,&nbsp;Vincent Doyle","doi":"10.1016/j.ceh.2024.12.001","DOIUrl":"10.1016/j.ceh.2024.12.001","url":null,"abstract":"<div><div>The rise of large language models (LLMs) and conversational applications, like ChatGPT, prompts Health Technology Assessment (HTA) bodies, such as NICE, to rethink how healthcare professionals access clinical guidance. Integrating LLMs into systems like Retrieval-Augmented Generation (RAG) offers potential solutions to current LLMs’ problems, like the generation of false or misleading information. The objective of this paper is to design and debate the value of an AI-driven system, similar to ChatGPT, to enhance the uptake of clinical guidance within the National Health Service (NHS) of the UK. Conversational interfaces, powered by LLMs, offer healthcare practitioners clear benefits over traditional ways of getting clinical guidance, such as easy navigation through long documents, blending information from various trusted sources, or expediting evidence-based decisions in situ. But, putting these interfaces into practice brings new challenges for HTA bodies, like assuring quality, addressing data privacy concerns, navigating existing resource constraints, or preparing the organization for innovative practices. Rigorous empirical evaluations are necessary to validate their effectiveness in increasing the uptake of clinical guidance among healthcare practitioners. A feasible evaluation strategy is elucidated in this research while its implementation remains as future work.</div></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"7 ","pages":"Pages 147-152"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143160908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a mobile health application for epilepsy self-management: Focus group discussion and validity of study results 开发用于癫痫自我管理的移动健康应用:焦点小组讨论和研究结果的有效性
Pub Date : 2024-12-01 DOI: 10.1016/j.ceh.2024.12.005
Iin Ernawati , Nanang Munif Yasin , Ismail Setyopranoto , Zullies Ikawati
Mobile health systems in the current digital era can be an opportunity for the development of health services, especially epilepsy, which is expected to help therapy management in monitoring drug therapy. Mobile health-based interventions have now begun to be developed for chronic disease management in managing stress, monitoring drug side effects, adherence to drug use, and seizures in epilepsy patients. To create the mobile health system, it is necessary to explore information not only from the literature but also from experts and patients. Therefore, this study aimed to examine what features/elements are needed in the mobile health system application. This study used a qualitative methodology with focus group discussion (FGD). The discussion process was recorded and transcribed verbatim, and the data was analyzed using thematic analysis with a descriptive interpretation approach. In addition, content validity by experts was also carried out from features or domains found in the literature and during FGD. The results of the FGD showed that the features needed for application development include patient profiles, drug reminders, information about diseases and drugs, medication records, side effects/adverse events records, records of frequency and triggers of seizures, application appearance, and ease of use. Based on the validity content by experts, all domains and features obtained (Items Content Validation Index) I-CVI values > 0.79 and were acceptable. In conclusion, this data can be used to develop the design and features of mobile health system applications for epilepsy patients.
在当前的数字时代,移动卫生系统可以成为发展卫生服务的一个机会,特别是癫痫,预计这将有助于监测药物治疗的治疗管理。现在已经开始开发基于健康的流动干预措施,用于慢性病管理,包括管理压力、监测药物副作用、坚持使用药物以及癫痫患者的癫痫发作。为了创建移动医疗系统,不仅需要从文献中探索信息,还需要从专家和患者中探索信息。因此,本研究旨在研究移动医疗系统应用程序需要哪些功能/元素。本研究采用焦点小组讨论(FGD)的定性方法。对讨论过程进行逐字记录和转录,并采用专题分析和描述性解释方法对数据进行分析。此外,专家的内容效度也从文献和FGD中发现的特征或领域进行。FGD的结果显示,应用程序开发所需的功能包括患者资料、药物提醒、疾病和药物信息、药物记录、副作用/不良事件记录、癫痫发作频率和触发因素记录、应用程序外观和易于使用。根据专家的有效性内容,得到所有领域和特征的(项目内容验证指数)I-CVI值>;0.79,可接受。总之,这些数据可用于开发癫痫患者移动卫生系统应用程序的设计和功能。
{"title":"Development of a mobile health application for epilepsy self-management: Focus group discussion and validity of study results","authors":"Iin Ernawati ,&nbsp;Nanang Munif Yasin ,&nbsp;Ismail Setyopranoto ,&nbsp;Zullies Ikawati","doi":"10.1016/j.ceh.2024.12.005","DOIUrl":"10.1016/j.ceh.2024.12.005","url":null,"abstract":"<div><div>Mobile health systems in the current digital era can be an opportunity for the development of health services, especially epilepsy, which is expected to help therapy management in monitoring drug therapy. Mobile health-based interventions have now begun to be developed for chronic disease management in managing stress, monitoring drug side effects, adherence to drug use, and seizures in epilepsy patients. To create the mobile health system, it is necessary to explore information not only from the literature but also from experts and patients. Therefore, this study aimed to examine what features/elements are needed in the mobile health system application. This study used a qualitative methodology with focus group discussion (FGD). The discussion process was recorded and transcribed verbatim, and the data was analyzed using thematic analysis with a descriptive interpretation approach. In addition, content validity by experts was also carried out from features or domains found in the literature and during FGD. The results of the FGD showed that the features needed for application development include patient profiles, drug reminders, information about diseases and drugs, medication records, side effects/adverse events records, records of frequency and triggers of seizures, application appearance, and ease of use. Based on the validity content by experts, all domains and features obtained (Items Content Validation Index) I-CVI values &gt; 0.79 and were acceptable. In conclusion, this data can be used to develop the design and features of mobile health system applications for epilepsy patients.</div></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"7 ","pages":"Pages 190-199"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143160898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
International collaboration in an online digital health education for undergraduate nursing students in China: Results and recommendations for course development from World eHealth Living Lab 中国本科护理学生在线数字健康教育的国际合作:世界电子健康生活实验室对课程开发的结果和建议
Pub Date : 2024-12-01 DOI: 10.1016/j.ceh.2024.11.001
Hongxia Shen , Cynthia Hallensleben , Haixing Shi , Rianne van der Kleij , Huohuo Dai , Niels Chavannes
Digital health enhances healthcare accessibility and should be integrated into nursing education to prepare future nurses for the evolving medical systems. An international collaboration between a Chinese medical university and World eHealth Living Lab of Leiden University Medical Center in the Netherlands developed and implemented the online course “Digital Health Empowerment and Nursing Innovation” for undergraduate nursing students in China. The course’s effectiveness was evaluated using a mixed methods approach, including a pre- and post-test assessing students’ scientific innovation ability, a post-test for protocol completion, students’ attitudes and satisfaction. 32 undergraduate nursing students completed the course, achieving a 100 % attendance rate and showing significant improvement in the total score of scientific innovation ability (37.87 ± 6.16 versus 40.97 ± 6.32, P = 0.049). Specifically, the score of thinking innovation improved significantly (17.31 ± 3.28 versus 19.28 ± 3.18, P = 0.017), while application innovation and scientific research practice scores remained unchanged. Participants highly rated the value of protocol writing with 23–25 (total score of 28) and presentation with 41–45 (total score of 48). Additionally, students reported high satisfaction with the aspects of this course including a well-structured schedule with lectures and workshops, feasible and sufficient materials on the online platform, and engaging and helpful teaching methods. Furthermore, suggestions of the course are mainly related to addressing the complexity of the platform, providing timely feedback and evaluation from teachers, and improving (online) interactions.This international collaboration effectively enhanced Chinese nursing students’ scientific innovation ability and thinking innovation, with high satisfaction reported. Future digital health education should emphasize practical research examples to implement innovations. Specifically, active teaching methods, such as practice units and student engagement in digital health innovation research implementation in clinical settings, are recommended for future courses. In areas with limited access to digital health specialists, online platforms can enhance access to high-quality medical education.
数字健康提高了医疗保健的可及性,并应纳入护理教育,为未来的护士为不断发展的医疗系统做好准备。中国医科大学与荷兰莱顿大学医学中心世界电子健康生活实验室合作,为中国护理本科学生开发并实施了“数字健康赋权与护理创新”在线课程。课程的有效性采用混合方法进行评估,包括评估学生科学创新能力的前测试和后测试,方案完成情况的后测试,学生的态度和满意度。32名本科护生完成课程,出勤率100%,科学创新能力总分显著提高(37.87±6.16比40.97±6.32,P = 0.049)。其中,思维创新得分显著提高(17.31±3.28比19.28±3.18,P = 0.017),应用创新和科研实践得分保持不变。参与者高度评价协议编写的价值23-25分(总分28分)和陈述的价值41-45分(总分48分)。此外,学生们对这门课程的各个方面都表示了很高的满意度,包括课程安排合理,有讲座和研讨会,在线平台上可行且充足的材料,以及吸引人且有用的教学方法。此外,课程的建议主要涉及解决平台的复杂性,及时提供教师的反馈和评估,以及改善(在线)互动。此次国际合作有效提升了我国护生的科技创新能力和思维创新能力,满意度较高。未来的数字健康教育应注重实践研究实例,实施创新。具体而言,建议在未来的课程中采用积极的教学方法,例如实践单元和学生参与临床环境中的数字健康创新研究实施。在获得数字卫生专家的机会有限的地区,在线平台可以增加获得高质量医学教育的机会。
{"title":"International collaboration in an online digital health education for undergraduate nursing students in China: Results and recommendations for course development from World eHealth Living Lab","authors":"Hongxia Shen ,&nbsp;Cynthia Hallensleben ,&nbsp;Haixing Shi ,&nbsp;Rianne van der Kleij ,&nbsp;Huohuo Dai ,&nbsp;Niels Chavannes","doi":"10.1016/j.ceh.2024.11.001","DOIUrl":"10.1016/j.ceh.2024.11.001","url":null,"abstract":"<div><div>Digital health enhances healthcare accessibility and should be integrated into nursing education to prepare future nurses for the evolving medical systems. An international collaboration between a Chinese medical university and World eHealth Living Lab of Leiden University Medical Center in the Netherlands developed and implemented the online course “Digital Health Empowerment and Nursing Innovation” for undergraduate nursing students in China. The course’s effectiveness was evaluated using a mixed methods approach, including a pre- and post-test assessing students’ scientific innovation ability, a post-test for protocol completion, students’ attitudes and satisfaction. 32 undergraduate nursing students completed the course, achieving a 100 % attendance rate and showing significant improvement in the total score of scientific innovation ability (37.87 ± 6.16 versus 40.97 ± 6.32, <em>P</em> = 0.049). Specifically, the score of thinking innovation improved significantly (17.31 ± 3.28 versus 19.28 ± 3.18, <em>P</em> = 0.017), while application innovation and scientific research practice scores remained unchanged. Participants highly rated the value of protocol writing with 23–25 (total score of 28) and presentation with 41–45 (total score of 48). Additionally, students reported high satisfaction with the aspects of this course including a well-structured schedule with lectures and workshops, feasible and sufficient materials on the online platform, and engaging and helpful teaching methods. Furthermore, suggestions of the course are mainly related to addressing the complexity of the platform, providing timely feedback and evaluation from teachers, and improving (online) interactions.This international collaboration effectively enhanced Chinese nursing students’ scientific innovation ability and thinking innovation, with high satisfaction reported. Future digital health education should emphasize practical research examples to implement innovations. Specifically, active teaching methods, such as practice units and student engagement in digital health innovation research implementation in clinical settings, are recommended for future courses. In areas with limited access to digital health specialists, online platforms can enhance access to high-quality medical education.</div></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"7 ","pages":"Pages 136-146"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142759749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expert consensus for smoking cessation with metaverse in medicine 专家共识戒烟与医学上的亚硝基
Pub Date : 2024-12-01 DOI: 10.1016/j.ceh.2024.10.001
Lian Wu , Dan Xiao , Weipen Jiang , Zhihao Jian , Katherine Song , Dawei Yang , Niels H. Chavannes , Chunxue Bai
{"title":"Expert consensus for smoking cessation with metaverse in medicine","authors":"Lian Wu ,&nbsp;Dan Xiao ,&nbsp;Weipen Jiang ,&nbsp;Zhihao Jian ,&nbsp;Katherine Song ,&nbsp;Dawei Yang ,&nbsp;Niels H. Chavannes ,&nbsp;Chunxue Bai","doi":"10.1016/j.ceh.2024.10.001","DOIUrl":"10.1016/j.ceh.2024.10.001","url":null,"abstract":"","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"7 ","pages":"Pages 164-175"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143160906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A narrative review of applications and enhancements of ChatGPT in respiratory medicine 综述了ChatGPT在呼吸医学中的应用和增强
Pub Date : 2024-12-01 DOI: 10.1016/j.ceh.2024.12.006
Jun Qi Lin , Zi Xuan Hua , Liu Zhang , Ying Ni Lin , Yong Jie Ding , Xi Xi Chen , Shi Qi Li , Yi Wang , Qing Yun Li
ChatGPT, a chatbot program pioneered by OpenAI and launched on 2022, stands alongside other notable large language models (LLMs) such as Google’s Bard Model and Baidu’s ERNIE Bot Model. These AI-powered tools have become integral to daily life, exerting considerable influence. Recently, AI’s medical applications gain traction as momentum grows. Meanwhile. chronic respiratory diseases pose a substantial global health burden, affecting nearly 550 million people in 2017, an increase of 39.8% compared to 1990. They remain a leading cause of death and disability worldwide, second only to cardiovascular diseases and cancer. The respiratory field grapples with unmet needs like antibiotic and anti-tuberculosis drug resistance, respiratory epidemics, and high prevalence of lung tumors, etc. Although the utilization of ChatGPT in medicine has been actively explored, its application in respiratory medicine remains in the early stages. In this context, we outline ChatGPT’s current respiratory medicine applications, address potential limitations, and envision future avenues for its advancement and development.
ChatGPT是由OpenAI开发的聊天机器人程序,于2022年推出,与b谷歌的Bard模型和b百度的ERNIE Bot模型等其他著名的大型语言模型(llm)并列。这些人工智能工具已经成为日常生活中不可或缺的一部分,产生了相当大的影响。最近,随着势头的增长,人工智能的医疗应用获得了牵引力。与此同时。慢性呼吸系统疾病造成了巨大的全球健康负担,2017年影响了近5.5亿人,比1990年增加了39.8%。它们仍然是全世界死亡和残疾的主要原因,仅次于心血管疾病和癌症。呼吸领域面临着未满足的需求,如抗生素和抗结核药物耐药性、呼吸道流行病和高患病率的肺部肿瘤等。虽然ChatGPT在医学上的应用已被积极探索,但其在呼吸医学上的应用仍处于早期阶段。在此背景下,我们概述了ChatGPT目前的呼吸医学应用,解决了潜在的局限性,并展望了其进步和发展的未来途径。
{"title":"A narrative review of applications and enhancements of ChatGPT in respiratory medicine","authors":"Jun Qi Lin ,&nbsp;Zi Xuan Hua ,&nbsp;Liu Zhang ,&nbsp;Ying Ni Lin ,&nbsp;Yong Jie Ding ,&nbsp;Xi Xi Chen ,&nbsp;Shi Qi Li ,&nbsp;Yi Wang ,&nbsp;Qing Yun Li","doi":"10.1016/j.ceh.2024.12.006","DOIUrl":"10.1016/j.ceh.2024.12.006","url":null,"abstract":"<div><div>ChatGPT, a chatbot program pioneered by OpenAI and launched on 2022, stands alongside other notable large language models (LLMs) such as Google’s Bard Model and Baidu’s ERNIE Bot Model. These AI-powered tools have become integral to daily life, exerting considerable influence. Recently, AI’s medical applications gain traction as momentum grows. Meanwhile. chronic respiratory diseases pose a substantial global health burden, affecting nearly 550 million people in 2017, an increase of 39.8% compared to 1990. They remain a leading cause of death and disability worldwide, second only to cardiovascular diseases and cancer. The respiratory field grapples with unmet needs like antibiotic and anti-tuberculosis drug resistance, respiratory epidemics, and high prevalence of lung tumors, etc. Although the utilization of ChatGPT in medicine has been actively explored, its application in respiratory medicine remains in the early stages. In this context, we outline ChatGPT’s current respiratory medicine applications, address potential limitations, and envision future avenues for its advancement and development.</div></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"7 ","pages":"Pages 200-206"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143160907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing automatic early arteriosclerosis prediction: an explainable machine learning evidence 增强自动早期动脉硬化预测:一个可解释的机器学习证据
Pub Date : 2024-12-01 DOI: 10.1016/j.ceh.2024.12.003
Eka Miranda , Suko Adiarto

Objective

This paper proposed a machine learning (ML) model to early predict patients with arteriosclerotic heart disease (AHD). We also used model-agnostic ML approaches to find and analyze informative aspects in the prediction model outcomes.

Methods

We employed an Electronic Health Record (EHR) for hematology that contained data on erythrocytes, hematocrit, hemoglobin, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, leukocytes, thrombocytes, age, and sex. Our investigation included Decision Tree (DT), Random Forest (RF), Logistic Regression (LR), Bagging Decision Tree (BDT), and Bagging Logistic Regression (BLR) for ML-based AHD detection. To handle imbalanced data and increase classifier accuracy, we used bagging and the Synthetic Minority Oversampling Technique (SMOTE). Following that, we used the Shapley Additive exPlanations (SHAP) framework to explain the ML model and quantify the feature contribution to predictions.

Results

SMOTE-balanced data with RF outperformed on practically all performance measures, including accuracy, precision, recall, f1-score, and ROCAUC, by 82.12 %, 81.31 %, 83.37 %, 82.57 %, and 89 %, respectively. According to the SHAP summary bar plot method for global feature importance, hemoglobin was the most important attribute for detecting and predicting AHD patients. Then, local interpretability in the form of a force plot illustrated the consequences of a single observation’s prediction as well as the magnitude of the SHAP value for each feature. Our findings demonstrated that hemoglobin, erythrocytes, hematocrit, hermch, khermchc, leukocytes, thrombocytes, and age all contributed positively to the prediction of class 1 (AHD patients), however gender had a negative impact on the prediction on a case-by-case basis. For class 0 (patients with no AHD), thrombocytes, hematocrit, and gender contributed positively, but leukocytes, erythrocytes, hemoglobin, and khermchc contributed adversely.

Conclusion

Explainable ML paved the way for early AHD prediction since it examined black-box ML models to determine how each feature contributed to the final prediction.
目的建立动脉硬化性心脏病(AHD)早期预测的机器学习(ML)模型。我们还使用与模型无关的ML方法来查找和分析预测模型结果中的信息方面。方法采用血液学电子健康记录(EHR),包括红细胞、红细胞比容、血红蛋白、平均红细胞血红蛋白、平均红细胞血红蛋白浓度、白细胞、血小板、年龄和性别等数据。我们的研究包括决策树(DT)、随机森林(RF)、逻辑回归(LR)、Bagging决策树(BDT)和Bagging Logistic回归(BLR)用于基于ml的AHD检测。为了处理不平衡数据并提高分类器的准确性,我们使用了装袋和合成少数过采样技术(SMOTE)。接下来,我们使用Shapley加性解释(SHAP)框架来解释ML模型,并量化特征对预测的贡献。结果使用RF的smot -balanced数据在准确率、精密度、召回率、f1-score和ROCAUC等几乎所有性能指标上分别高出82.12%、81.31%、83.37%、82.57%和89%。根据SHAP总体特征重要性汇总条形图方法,血红蛋白是检测和预测AHD患者最重要的属性。然后,以力图形式的局部可解释性说明了单个观测预测的结果以及每个特征的SHAP值的大小。我们的研究结果表明,血红蛋白、红细胞、红细胞压积、hermch、khermchc、白细胞、血小板和年龄都对1级(AHD患者)的预测有积极的影响,而性别对个案预测有负面影响。对于0级(无AHD患者),血小板、红细胞压积和性别有积极作用,但白细胞、红细胞、血红蛋白和血红蛋白有不利作用。可解释ML为早期AHD预测铺平了道路,因为它检查了黑箱ML模型,以确定每个特征如何对最终预测做出贡献。
{"title":"Enhancing automatic early arteriosclerosis prediction: an explainable machine learning evidence","authors":"Eka Miranda ,&nbsp;Suko Adiarto","doi":"10.1016/j.ceh.2024.12.003","DOIUrl":"10.1016/j.ceh.2024.12.003","url":null,"abstract":"<div><h3>Objective</h3><div>This paper proposed a machine learning (ML) model to early predict patients with arteriosclerotic heart disease (AHD). We also used model-agnostic ML approaches to find and analyze informative aspects in the prediction model outcomes.</div></div><div><h3>Methods</h3><div>We employed an Electronic Health Record (EHR) for hematology that contained data on erythrocytes, hematocrit, hemoglobin, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, leukocytes, thrombocytes, age, and sex. Our investigation included Decision Tree (DT), Random Forest (RF), Logistic Regression (LR), Bagging Decision Tree (BDT), and Bagging Logistic Regression (BLR) for ML-based AHD detection. To handle imbalanced data and increase classifier accuracy, we used bagging and the Synthetic Minority Oversampling Technique (SMOTE). Following that, we used the Shapley Additive exPlanations (SHAP) framework to explain the ML model and quantify the feature contribution to predictions.</div></div><div><h3>Results</h3><div>SMOTE-balanced data with RF outperformed on practically all performance measures, including accuracy, precision, recall, f1-score, and ROCAUC, by 82.12 %, 81.31 %, 83.37 %, 82.57 %, and 89 %, respectively. According to the SHAP summary bar plot method for global feature importance, hemoglobin was the most important attribute for detecting and predicting AHD patients. Then, local interpretability in the form of a force plot illustrated the consequences of a single observation’s prediction as well as the magnitude of the SHAP value for each feature. Our findings demonstrated that hemoglobin, erythrocytes, hematocrit, hermch, khermchc, leukocytes, thrombocytes, and age all contributed positively to the prediction of class 1 (AHD patients), however gender had a negative impact on the prediction on a case-by-case basis. For class 0 (patients with no AHD), thrombocytes, hematocrit, and gender contributed positively, but leukocytes, erythrocytes, hemoglobin, and khermchc contributed adversely.</div></div><div><h3>Conclusion</h3><div>Explainable ML paved the way for early AHD prediction since it examined black-box ML models to determine how each feature contributed to the final prediction.</div></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"7 ","pages":"Pages 153-163"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143160909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leveraging deep edge intelligence for real-time respiratory disease detection 利用深度边缘智能实时检测呼吸系统疾病
Pub Date : 2024-12-01 DOI: 10.1016/j.ceh.2025.01.001
Tahiya Tasneem Oishee, Jareen Anjom, Uzma Mohammed, Md. Ishan Arefin Hossain
Detecting respiratory diseases such as COPD, bronchiolitis, URTI, and pneumonia is crucial for early medical intervention. This study utilizes the ICBHI dataset to train and evaluate deep learning architectures such as CNN-GRU, VGGish, YAMNet, CNN-LSTM, and basic CNN to automate this process. After a detailed analysis of the performance of these models, the CNN-LSTM model achieved an impressive accuracy and F1 score of 96% each. The model is also considerably lightweight, as its weights are further pruned and then quantized using TensorFlow Lite (TFLite), with the model being optimized at a significantly small size of 0.38 MB with only a loss of about 1% in performance. Subsequently, this was deployed to the smartphone application RespiScan. The application uses the prediction capabilities of the disease detection model on patients’ audio recordings. By providing a portable, cost-effective, and efficient, lightweight solution for respiratory health monitoring, this work contributes significantly to timely disease detection. It promotes proactive health management, thereby reducing the burden on healthcare systems. This work can be further validated in real-world conditions, such as for initial preliminary auscultation purposes, to ensure the proposed work’s efficacy across different environmental settings.
检测呼吸道疾病,如慢性阻塞性肺病、细支气管炎、尿路感染和肺炎,对早期医疗干预至关重要。本研究利用ICBHI数据集来训练和评估CNN- gru、VGGish、YAMNet、CNN- lstm和basic CNN等深度学习架构,以实现这一过程的自动化。经过对这些模型性能的详细分析,CNN-LSTM模型取得了令人印象深刻的准确率和96%的F1分数。该模型也是相当轻量级的,因为它的权重被进一步修剪,然后使用TensorFlow Lite (TFLite)进行量化,模型在0.38 MB的小尺寸上进行了优化,性能只损失了大约1%。随后,它被部署到智能手机应用程序RespiScan中。该应用程序利用疾病检测模型对患者录音的预测能力。通过为呼吸系统健康监测提供便携、经济、高效、轻量级的解决方案,这项工作为及时发现疾病做出了重大贡献。它促进积极主动的卫生管理,从而减轻卫生保健系统的负担。这项工作可以在现实条件下进一步验证,例如用于初始初步听诊目的,以确保所提议的工作在不同环境设置中的有效性。
{"title":"Leveraging deep edge intelligence for real-time respiratory disease detection","authors":"Tahiya Tasneem Oishee,&nbsp;Jareen Anjom,&nbsp;Uzma Mohammed,&nbsp;Md. Ishan Arefin Hossain","doi":"10.1016/j.ceh.2025.01.001","DOIUrl":"10.1016/j.ceh.2025.01.001","url":null,"abstract":"<div><div>Detecting respiratory diseases such as COPD, bronchiolitis, URTI, and pneumonia is crucial for early medical intervention. This study utilizes the ICBHI dataset to train and evaluate deep learning architectures such as CNN-GRU, VGGish, YAMNet, CNN-LSTM, and basic CNN to automate this process. After a detailed analysis of the performance of these models, the CNN-LSTM model achieved an impressive accuracy and F1 score of 96% each. The model is also considerably lightweight, as its weights are further pruned and then quantized using TensorFlow Lite (TFLite), with the model being optimized at a significantly small size of 0.38 MB with only a loss of about 1% in performance. Subsequently, this was deployed to the smartphone application RespiScan. The application uses the prediction capabilities of the disease detection model on patients’ audio recordings. By providing a portable, cost-effective, and efficient, lightweight solution for respiratory health monitoring, this work contributes significantly to timely disease detection. It promotes proactive health management, thereby reducing the burden on healthcare systems. This work can be further validated in real-world conditions, such as for initial preliminary auscultation purposes, to ensure the proposed work’s efficacy across different environmental settings.</div></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"7 ","pages":"Pages 207-220"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143160899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A survey on define daily dose of watch- and access-category antibiotics in two Indonesian hospitals following the implementation of digital antimicrobial stewardship tool 在实施数字抗微生物药物管理工具后,对印度尼西亚两家医院的监测类和可获得类抗生素的确定日剂量进行了调查
Pub Date : 2024-12-01 DOI: 10.1016/j.ceh.2024.12.004
Ronald Irwanto Natadidjaja , Aziza Ariyani , Hadianti Adlani , Raymond Adianto , Iin Indah Pertiwi , Grace Nerry Legoh , Alvin Lekonardo Rantung , Hadi Sumarsono

Background

In 2023, the World Health Organization (WHO) began targeting a shift in antibiotic prescribing trends from Watch to Access category. The expected target is including 60% of antibiotic prescribing in the Access category.

Method

This survey was a preliminary study, in which our study group designed a digital model of antimicrobial stewardship and the model was known as e-RASPRO. It was an initial review on the implementation of e-RASPRO tool prior to its wider use in future hospitals. The survey on the use of antibiotic Define Daily Dose / 100 patient days (DDD) was carried out in two hospitals in Indonesia at 3 months and 9 months of use, respectively. Hospital 1 as a primary hospital, Hospital 2 as a referral hospital. Data was retrieved retrospectively at the inpatient wards of both hospitals.

Result

Three months before and after the implementation of e-RASPRO in Hospital 1, we found an increase in DDD of prophylactic antibiotic Cefazolin by 167.18 %. In hospital 2, it could not be described because Cefazolin had been used since the hospital applied the manual RASPRO concept. DDD of Watch category antibiotics within 9 months following the implementation of e-RASPRO tool in hospital 1 showed a decrease of 49.01 %. Meanwhile, the implementation of e-RASPRO for 3 months in Hospital 2 still showed an increase in Watch category antibiotics by 20.18 %; however, there was a decrease in DDD of Cephalosporin and Glycopeptide antibiotics by 7.63 % and 49.30 %, respectively. In the meantime, as a way of saving antibiotic use and shifting antibiotic prescribing to the Access category, we found a decrease in DDD of Access category antibiotics in Hospital 1 by 3.64 % and an increase in Hospital 2 by 8.14 %

Conclusion

The survey may indicate that there are savings attempts in antibiotic use as well as an early change in DDD antibiotics from the Watch category to the Access category following the implementation of e-RASPRO tool in both hospitals. The time period of using the digital devices may still affect the results; however, this survey certainly has not illustrated a strong cause-and-effect correlation between the use of e-RASPRO tool and antibiotic DDD.
2023年,世界卫生组织(世卫组织)开始瞄准抗生素处方趋势的转变,从观察到获取类别。预期目标是将60%的抗生素处方纳入可及性类别。方法本研究是一项初步研究,本研究组设计了抗菌药物管理数字模型,该模型称为e-RASPRO。这是在未来医院更广泛使用e-RASPRO工具之前对其实施情况的初步审查。在印度尼西亚的两家医院,分别在使用抗生素3个月和9个月时,对抗生素确定每日剂量/ 100病人日(DDD)的使用情况进行了调查。第一医院是初级医院,第二医院是转诊医院。回顾性检索两家医院住院病房的资料。结果1院实施e-RASPRO前后3个月预防性抗生素头孢唑林的DDD增加了167.18%。在医院2,由于医院采用手动RASPRO概念,头孢唑林一直在使用,因此无法描述。1医院实施e-RASPRO工具后9个月内Watch类抗生素DDD下降49.01%。同时,在第二医院实施e-RASPRO 3个月后,Watch类抗生素仍增加20.18%;头孢菌素类和糖肽类抗生素的DDD分别下降了7.63%和49.30%。与此同时,作为一种节约使用抗生素和抗生素处方转向访问类别,我们发现减少DDD的访问类抗生素在医院1 3.64%,增加医院2 8.14% ConclusionThe调查可能表明有储蓄的尝试在抗生素的使用以及早期改变DDD抗生素从手表类别访问类别后e-RASPRO工具的实现在两个医院。使用数字设备的时间仍可能影响结果;然而,这项调查肯定没有说明使用e-RASPRO工具和抗生素DDD之间存在很强的因果关系。
{"title":"A survey on define daily dose of watch- and access-category antibiotics in two Indonesian hospitals following the implementation of digital antimicrobial stewardship tool","authors":"Ronald Irwanto Natadidjaja ,&nbsp;Aziza Ariyani ,&nbsp;Hadianti Adlani ,&nbsp;Raymond Adianto ,&nbsp;Iin Indah Pertiwi ,&nbsp;Grace Nerry Legoh ,&nbsp;Alvin Lekonardo Rantung ,&nbsp;Hadi Sumarsono","doi":"10.1016/j.ceh.2024.12.004","DOIUrl":"10.1016/j.ceh.2024.12.004","url":null,"abstract":"<div><h3>Background</h3><div>In 2023, the World Health Organization (WHO) began targeting a shift in antibiotic prescribing trends from Watch to Access category. The expected target is including 60% of antibiotic prescribing in the Access category.</div></div><div><h3>Method</h3><div>This survey was a preliminary study, in which our study group designed a digital model of antimicrobial stewardship and the model was known as e-RASPRO. It was an initial review on the implementation of e-RASPRO tool prior to its wider use in future hospitals. The survey on the use of antibiotic Define Daily Dose / 100 patient days (DDD) was carried out in two hospitals in Indonesia at 3 months and 9 months of use, respectively. Hospital 1 as a primary hospital, Hospital 2 as a referral hospital. Data was retrieved retrospectively at the inpatient wards of both hospitals.</div></div><div><h3>Result</h3><div>Three months before and after the implementation of e-RASPRO in Hospital 1, we found an increase in DDD of prophylactic antibiotic Cefazolin by 167.18 %. In hospital 2, it could not be described because Cefazolin had been used since the hospital applied the manual RASPRO concept. DDD of Watch category antibiotics within 9 months following the implementation of e-RASPRO tool in hospital 1 showed a decrease of 49.01 %. Meanwhile, the implementation of e-RASPRO for 3 months in Hospital 2 still showed an increase in Watch category antibiotics by 20.18 %; however, there was a decrease in DDD of Cephalosporin and Glycopeptide antibiotics by 7.63 % and 49.30 %, respectively. In the meantime, as a way of saving antibiotic use and shifting antibiotic prescribing to the Access category, we found a decrease in DDD of Access category antibiotics in Hospital 1 by 3.64 % and an increase in Hospital 2 by 8.14 %</div></div><div><h3>Conclusion</h3><div>The survey may indicate that there are savings attempts in antibiotic use as well as an early change in DDD antibiotics from the Watch category to the Access category following the implementation of e-RASPRO tool in both hospitals. The time period of using the digital devices may still affect the results; however, this survey certainly has not illustrated a strong cause-and-effect correlation between the use of e-RASPRO tool and antibiotic DDD.</div></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"7 ","pages":"Pages 176-189"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143159891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“AI et al.” The perils of overreliance on Artificial Intelligence by authors in scientific research "人工智能等"科学研究中作者过度依赖人工智能的危害
Pub Date : 2024-09-17 DOI: 10.1016/j.ceh.2024.09.001
Juan S. Izquierdo-Condoy, Jorge Vásconez-González, Esteban Ortiz-Prado
The rapid integration of Artificial Intelligence (AI) into scientific research and publication processes marks a significant shift in knowledge generation. This transition from traditional literature searches to AI-driven algorithms has accelerated tasks such as writing, editing, and summarizing scientific manuscripts. While AI holds promise for improving efficiency and accuracy, concerns have arisen about its potential misuse and the erosion of scientific integrity.
人工智能(AI)与科学研究和出版流程的快速融合标志着知识生成的重大转变。从传统的文献检索到人工智能驱动算法的转变,加速了科学手稿的撰写、编辑和总结等任务。虽然人工智能在提高效率和准确性方面大有可为,但其潜在的滥用和对科学诚信的侵蚀也引起了人们的担忧。
{"title":"“AI et al.” The perils of overreliance on Artificial Intelligence by authors in scientific research","authors":"Juan S. Izquierdo-Condoy,&nbsp;Jorge Vásconez-González,&nbsp;Esteban Ortiz-Prado","doi":"10.1016/j.ceh.2024.09.001","DOIUrl":"10.1016/j.ceh.2024.09.001","url":null,"abstract":"<div><div>The rapid integration of Artificial Intelligence (AI) into scientific research and publication processes marks a significant shift in knowledge generation. This transition from traditional literature searches to AI-driven algorithms has accelerated tasks such as writing, editing, and summarizing scientific manuscripts. While AI holds promise for improving efficiency and accuracy, concerns have arisen about its potential misuse and the erosion of scientific integrity.</div></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"7 ","pages":"Pages 133-135"},"PeriodicalIF":0.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S258891412400011X/pdfft?md5=70c6586f1ccff88f9064013143660cc2&pid=1-s2.0-S258891412400011X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142314099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical eHealth
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1